跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ULTRAVIST 240 Iopromide 24.936g/50mL injection - TGA Drug Approval Details
Approvals
/
TGA
/
ULTRAVIST 240 Iopromide 24.936g/50mL injection
Approved
STANDARD
ULTRAVIST 240 Iopromide 24.936g/50mL injection
Bayer Australia Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
53d4fe353ecdfe27
Company
Bayer Australia Ltd
Type
Standard
Approval Details
Approval Id
53d4fe353ecdfe27
Product Name
ULTRAVIST 240 Iopromide 24.936g/50mL injection
Artg Id
15709
Artg Name
ULTRAVIST 240 iopromide 24.936g/50mL injection bottle
Sponsor
Bayer Australia Ltd
Company Detail Path
/organization/bayer-australia-ltd
Artg Date
1991-09-12
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/af4755250cbb1b69a5f3d43181d3438f.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/bea58b879a485a29e2cddeee327e1bee.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
53d4fe353ecdfe27
Type
Standard
Back to TGA Approvals